Xiamen, China

Shaowei Li


 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Hangzhou, CN (2013 - 2014)
  • Xiamen, CN (2010 - 2022)
  • Fujian, CN (2009 - 2023)

Company Filing History:


Years Active: 2009-2024

Loading Chart...
Loading Chart...
26 patents (USPTO):

Title: Innovations in HPV Research: The Work of Shaowei Li

Introduction

Shaowei Li is an accomplished inventor located in Xiamen, China, known for his significant contributions to the field of virology. With 26 patents to his name, Li has focused his research on the development of innovative therapies and vaccines for human papillomavirus (HPV), particularly targeting types associated with cervical cancer.

Latest Patents

Li's latest patents showcase his groundbreaking work on mutated proteins and virus-like particles. One notable patent involves the development of a mutated HPV type 51 L1 protein or a variant thereof. This invention outlines a coding sequence and method for preparing the protein, as well as a virus-like particle capable of inducing neutralizing antibodies against multiple HPV types, including HPV51 and HPV69. The applications for this invention are crucial, as they contribute to the preparation of pharmaceutical compositions and vaccines aimed at preventing HPV infections and related diseases like cervical cancer and condyloma acuminatum.

Another significant patent by Li pertains to a mutant of the L1 protein of human papillomavirus type 18. This invention details a similar approach, where the mutated protein and the associated virus-like particle can induce neutralizing antibodies against HPV types 18, 45, and 59. Again, the implications for vaccine development and treatment strategies for HPV-related diseases are profound.

Career Highlights

Throughout his career, Shaowei Li has worked at esteemed institutions such as Xiamen University and Xiamen Innovax Biotech Co., Ltd. His affiliation with these organizations highlights his commitment to advancing research in infectious diseases and developing innovative health solutions.

Collaborations

Li has collaborated with notable peers in the field, including Ningshao Xia and Jun Zhang. These collaborations have likely enriched his research and accelerated developments in HPV vaccine technology.

Conclusion

In summary, Shaowei Li's work represents a significant advancement in HPV research, particularly through his innovative patents focusing on mutated proteins and vaccine formulations. His contributions not only reflect his expertise but also pave the way for effective interventions against HPV-related diseases, making him a valuable asset to the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…